APA (7th ed.) Citation

Kim, D., Hong, Y. S., Kim, J. E., Kim, K., Lee, J., Chun, S., . . . Kim, T. W. (2017). Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer. Cancer research and treatment, 49(1), 37-43. https://doi.org/10.4143/crt.2016.069

Chicago Style (17th ed.) Citation

Kim, Dalyong, Yong Sang Hong, Jeong Eun Kim, Kyu-pyo Kim, Jae-Lyun Lee, Sung-Min Chun, Jihun Kim, Se Jin Jang, and Tae Won Kim. "Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer." Cancer Research and Treatment 49, no. 1 (2017): 37-43. https://doi.org/10.4143/crt.2016.069.

MLA (9th ed.) Citation

Kim, Dalyong, et al. "Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer." Cancer Research and Treatment, vol. 49, no. 1, 2017, pp. 37-43, https://doi.org/10.4143/crt.2016.069.